Prosecution Insights
Last updated: October 04, 2026

Shaklee Corporation

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Shaklee Corporation is active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This single active matter indicates a focused prosecution phase for the company's intellectual property. The firm is currently working to resolve this outstanding action to advance its application toward allowance.

The portfolio is reviewed by 1 distinct examiner and 1 distinct art unit. This one-to-one ratio between examiners and art units shows that the company's current work is concentrated within a specific technical department. Practitioners can expect a consistent examination environment, as there is no variation in the personnel or departmental standards currently being applied to the portfolio.

ARMSTRONG, SUSANNAH SIPPLE is the busiest examiner for this company. This examiner is responsible for the 1 busiest examiner pending office action. Since ARMSTRONG, SUSANNAH SIPPLE handles the only active matter, the outcome of the entire pending portfolio depends on the interaction with this single individual. The concentration of work under ARMSTRONG, SUSANNAH SIPPLE allows for a focus on this examiner's specific requirements and historical patterns.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ARMSTRONG, SUSANNAH SIPPLE 1 30.0% +53.1%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18227138 BOTANICAL EXTRACT BLEND FOR USE IN SKIN CARE ARMSTRONG, SUSANNAH SIPPLE 34d

Top Art Units

Art UnitApps
1616 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18227138 BOTANICAL EXTRACT BLEND FOR USE IN SKIN CARE ARMSTRONG, SUSANNAH SIPPLE 1616 §103Other Non-Final OA 34d Pending Jul 27, 2023

Managing Shaklee Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month